Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Recombinant or stably-transformed bacterium encoding one or...
Patent
1975-05-21
1977-01-25
Drezin, Norman A.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Recombinant or stably-transformed bacterium encoding one or...
A61K 31195
Patent
active
040052222
ABSTRACT:
A mucolytic process is disclosed which comprises contacting N-(2-hydroxyethyl)mercaptoacetamidobenzamides or mercaptoacylamidobenzoic acids, mercaptoacetylsulfanilic acids and alkanoylthio derivatives thereof with mucus. Illustrative of compounds useful in the mucolytic process of the present invention are 4-(2-mercaptoacetamido)benzoic acid and N-(2-mercaptoacetyl)sulfanilic acid.
REFERENCES:
patent: 2448939 (1948-09-01), Weissberger et al.
patent: 2520293 (1950-08-01), Weiss
patent: 2607789 (1952-08-01), Weiss
patent: 3091569 (1963-05-01), Sheffner
patent: 3663690 (1972-05-01), Eichel et al.
patent: 3770824 (1973-11-01), Phillips et al.
patent: 3809697 (1971-10-01), Martin et al.
A. L. Sheffenr, Ann. New York Acad. Sci., 106, 298-310, (1963).
N. S. Poonia et al., Indian. J. Appl. Chem., 27(1) 32-33 (1964).
Comer William Timmey
Martin Tellis Alexander
Carnahan R. E.
Drezin Norman A.
Mead Johnson & Company
Uloth R. H.
LandOfFree
Mucolytic mercaptoacylamidobenzoic and benzenesulfonic acid comp does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Mucolytic mercaptoacylamidobenzoic and benzenesulfonic acid comp, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Mucolytic mercaptoacylamidobenzoic and benzenesulfonic acid comp will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1479304